Clinical Trial Update: Extension Study of Protocol ENB-002-08 - Study of Asfotase Alfa in Infants and Young Children With Hypophosphatasia (HPP) [Phase 2]

View source ↗

Summary

Extension study update for asfotase alfa in infants and young children with hypophosphatasia (Phase 2) completed; results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypophosphatasia

Drugs mentioned

• Asfotase alfa (asfotase alfa)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Hypophosphatasia | Phase 2 | Status: COMPLETED | Results posted: 2017-11-17